407 results match your criteria Eosinophilic Folliculitis


Clearance of atypical cutaneous manifestations of hyper-IgE syndrome with dupilumab.

Pediatr Dermatol 2022 Jun 22. Epub 2022 Jun 22.

Department of Dermatology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.

Hyper-IgE syndromes (HIES) are a heterogeneous group of rare primary immunodeficiency diseases classically characterized by the triad of atopic dermatitis, and recurrent cutaneous and pulmonary infections. Autosomal dominant, loss-of-function STAT3 pathogenic variants are the most common genetic cause, which lead to deficiency of Th17 lymphocytes, impaired interferon gamma production, and IL-10 signal transduction, and an unbalanced IL-4 state. Dupilumab, a monoclonal antibody to the IL-4a receptor, inhibits both IL-4 and IL-13, and has been shown to improve atopic dermatitis and other manifestations of HIES including asthma and allergic bronchopulmonary aspergillosis. Read More

View Article and Full-Text PDF

Eosinophilic pustular folliculitis of infancy.

Arch Dis Child Fetal Neonatal Ed 2022 Jun 21. Epub 2022 Jun 21.

Department of Dermatology, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, China.

View Article and Full-Text PDF

Eosinophilic pustular folliculitis developed at the site of COVID-19 vaccination.

Clin Exp Dermatol 2022 Jun 14. Epub 2022 Jun 14.

Department of Dermatology, Shiga University of Medical Science, Setatsukinowa, Otsu, Shiga, 520-2192, Japan.

View Article and Full-Text PDF

Eosinophilic Pustular Folliculitis of Infancy: A Histologic Assessment of 43 Cases.

Am J Dermatopathol 2022 Jun 5;44(6):395-403. Epub 2021 Aug 5.

Consultant Physician, Pathologist, Department of Pathology, Necker-Enfants Malades Hospital, and Reference Center for Genodermatoses, Necker-Enfants Malades Hospital, Paris, France.

Abstract: Eosinophilic pustular folliculitis of infancy is a sterile, inflammatory dermatosis that mainly affects children younger than 36 months. The underlying physiopathologic mechanism is unclear. Clinical diagnosis is challenging, and a skin biopsy may be necessary. Read More

View Article and Full-Text PDF

A case of eosinophilic pustular folliculitis successfully treated with adalimumab.

Dermatol Ther 2022 May 4:e15550. Epub 2022 May 4.

Medical Area Department, U.O.C. Dermatologia, P.O. San Marco, Catania, Italy.

View Article and Full-Text PDF

A Case Report of Necrotizing Eosinophilic Folliculitis Occurring After Rhus Ingestion.

Clin Cosmet Investig Dermatol 2022 24;15:313-317. Epub 2022 Feb 24.

Department of Dermatology, College of Medicine, Chungbuk National University, Cheongju, Korea.

Necrotizing eosinophilic folliculitis is known as a rare variant of eosinophilic folliculitis (EF). It differs from classic EF because of its necrotizing ulcerative clinical course. We report a case of necrotizing eosinophilic folliculitis accompanied by pathergic phenomenon that may be the result of a delayed type hypersensitivity reaction occurring after Rhus consumption. Read More

View Article and Full-Text PDF
February 2022

A Dermatitis Mimicker: A Case of Infantile Eosinophilic Pustular Folliculitis.

Dermatitis 2022 Jan-Feb 01;33(1):e1

From the LSU-Health Sciences Center New Orleans School of Medicine, LA.

View Article and Full-Text PDF
February 2022

A vulvar pseudotumor: A rare clinical presentation of eosinophilic folliculitis.

Int J Gynaecol Obstet 2022 05 23;157(2):484-485. Epub 2021 Nov 23.

Pathology Department, Complejo Hospitalario de Navarra, Pamplona, Spain.

View Article and Full-Text PDF

Role of food allergy in the etiology of infantile eosinophilic pustular folliculitis.

Pediatr Allergy Immunol 2022 01 10;33(1):e13687. Epub 2021 Nov 10.

Department of Family Medicine, Bulent Ecevit University School of Medicine, Zonguldak, Turkey.

View Article and Full-Text PDF
January 2022

Treatment of eosinophilic pustular folliculitis with low-dose isotretinoin.

Int J Dermatol 2022 07 30;61(7):e262-e264. Epub 2021 Sep 30.

Department of Medical Sciences, Dermatology Clinic, University of Turin, Turin, Italy.

View Article and Full-Text PDF

Eosinophilic cellulitis with pustular lesions.

Int J Dermatol 2022 06 9;61(6):e227-e228. Epub 2021 Jul 9.

Department of Dermatology, Asahikawa Medical University, Asahikawa, Japan.

View Article and Full-Text PDF

Eosinophilic pustular folliculitis of infancy: A rare diagnosis in children.

Clin Case Rep 2021 May 11;9(5):e04167. Epub 2021 May 11.

Department of Dermatology Aarhus University Hospital Aarhus Denmark.

Remember EPFI as a differential diagnosis in children with a rash on the scalp and no effect of antibiotic treatment. Read More

View Article and Full-Text PDF

Predictive Model for Differential Diagnosis of Inflammatory Papular Dermatoses of the Face.

Ann Dermatol 2020 Aug 30;32(4):298-305. Epub 2020 Jun 30.

Department of Dermatology, Seoul National University Bundang Hospital, Seongnam, Korea.

Background: The clinical features of inflammatory papular dermatoses of the face are very similar. Their clinical manifestations have been described on the basis of a small number of case reports and are not specific.

Objective: This study aimed to use computer-aided image analysis (CAIA) to compare the clinical features and parameters of inflammatory papular dermatoses of the face and to develop a formalized diagnostic algorithm based on the significant findings. Read More

View Article and Full-Text PDF

Infantile Eosinophilic Pustular Folliculitis: A Case Report.

J Cosmet Dermatol 2022 Mar 6;21(3):1143-1146. Epub 2021 May 6.

Department of Pathology, Selcuk University Faculty of Medicine, Konya, Turkey.

Background: Infantile eosinophilic pustular folliculitis (I-EPF) is a rare disease characterized by pruritic vesicles and sterile pustules on the erythematous surface of the scalp and facial localization, usually seen in the neonatal period. It is essential to show the presence of dense eosinophils in the diagnosis of pustules. Histopathological examination of the hair follicles by eosinophils infiltration is determined. Read More

View Article and Full-Text PDF

Uncommon localisation of Ofuji disease in a Moroccan patient.

BMJ Case Rep 2021 Apr 13;14(4). Epub 2021 Apr 13.

Dermatology-Venerology Department, Mohammed V University of Rabat, Rabat, Morocco.

View Article and Full-Text PDF

Eosinophilic folliculitis, eosinophilic dermatosis of hematologic malignancy and acneiform follicular mucinosis: Two case reports and a review of the literature highlighting the spectrum of histopathology.

J Cutan Pathol 2021 Mar 18;48(3):439-450. Epub 2020 Dec 18.

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.

Within the literature, there is overlap in the histopathological features described in eosinophilic folliculitis associated with chronic lymphocytic leukemia (CLL), eosinophilic dermatosis of hematologic malignancy, and acneiform follicular mucinosis. These disorders are described with varying degrees of superficial and deep lymphocytic and eosinophilic inflammation demonstrating perivascular, perifollicular, and folliculocentric involvement with or without follicular mucin deposition. Given significant histopathological overlap, these diagnoses may represent a continuum on a spectrum of dermatoses. Read More

View Article and Full-Text PDF

Treatment of eosinophilic pustular folliculitis with benralizumab in a 13-year-old girl.

J Eur Acad Dermatol Venereol 2021 Jun 10;35(6):e401-e403. Epub 2021 Mar 10.

Pediatric Skin Center, Dermatology Department, University Children's Hospital Zurich, Zurich, Switzerland.

View Article and Full-Text PDF

A Case of Eosinophilic Pustular Folliculitis since Birth.

Children (Basel) 2021 Jan 7;8(1). Epub 2021 Jan 7.

Department of Dermatology, Ehime University Graduate School of Medicine, Ehime 791-0295, Japan.

A newborn male infant presented with multiple pustules and erosions with erythema involving his scalp and forehead at birth. One week after birth, new pustules continued to appear, forming crusted, ring-shaped plaques with pigmentation. Tests for possible pathogens were negative. Read More

View Article and Full-Text PDF
January 2021

Eosinophilic pustular folliculitis (EPF) in a patient with HIV infection.

Infection 2021 Aug 25;49(4):799-801. Epub 2020 Nov 25.

Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Hufelandstr. 55, 45122, Essen, Germany.

Eosinophilic pustular folliculitis is a chronic, recurrent dermatosis, of unknown etiology, which is histologically characterized by folliculotropic inflammatory infiltrates with admixed eosinophils in the dermis. It has often presented with immunosuppression and especially with HIV-Infection. In the HAART-era, eosinophilic pustular folliculitis has become a rarity. Read More

View Article and Full-Text PDF

A Case of Eosinophilic Pustular Folliculitis Associated With Herpes Zoster.

Am J Dermatopathol 2021 Apr;43(4):298-299

Department of Dermatology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Republic of Korea.

Abstract: Patients with eosinophilic pustular folliculitis (EPF), a sterile eosinophilic infiltration of hair follicles, often present with papulopustules that tend to form annular plaques. Histopathologic examination revealed eosinophilic infiltration around the pilosebaceous units and eosinophilic microabscess formation. Although the pathogenesis of EPF is unknown, T-helper type 2 immune responses were suggested to be important based on their stimulating effect on the sebaceous glands. Read More

View Article and Full-Text PDF

Papuloerythroderma of Ofuji.

JAMA Dermatol 2020 12;156(12):1365

Department of Dermatology, National Clinical Research Center for Dermatologic and Immunologic Diseases, Translational Medicine Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

View Article and Full-Text PDF
December 2020

Eosinophilic folliculitis due to wearing protective gear in citizens volunteering for sanitation services during the COVID-19 pandemic - an original epidemiological, clinical, dermoscopic, and laboratory-based study.

Authors:
Antonio Chuh

Int J Dermatol 2020 Dec 11;59(12):1468-1474. Epub 2020 Oct 11.

Department of Family Medicine and Primary Care, The University of Hong Kong and Queen Mary Hospital, Pokfulam, Hong Kong.

Background: An association between wearing protective gear and eosinophilic folliculitis has not been reported. We aimed to investigate such during the COVID-19 pandemic.

Methods: In three outpatient clinics, we hand-reviewed records of all patients having consulted us during a Study Period (90 days) in the early phase of the pandemic. Read More

View Article and Full-Text PDF
December 2020

A Case of Ofuji Disease Successfully Treated with the Combination of Low-Dose Indomethacin and Topical Tacrolimus.

Case Rep Dermatol 2020 May-Aug;12(2):155-158. Epub 2020 Aug 18.

Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Eosinophilic pustular folliculitis (EPF) (Ofuji disease) is a chronic, noninfectious pruritic cutaneous disorder of unknown etiology. No official guidelines are available for its treatment. Herein we present the case of a 59-year-old Caucasian man admitted to our outpatient clinic due to a generalized itchy skin rash characterized by papulo-pustules involving the face, trunk, and limbs. Read More

View Article and Full-Text PDF

Human Polyomavirus 6 Detected in Cases of Eosinophilic Pustular Folliculitis.

J Infect Dis 2021 05;223(10):1724-1732

Department of Microbiology and Infection, Kochi Medical School, Kochi University, Kochi, Japan.

Background: Human polyomaviruses (HPyVs) have been associated with several cutaneous inflammatory conditions. More investigation is needed to identify further presentations of cutaneous pathology associated with HPyVs. Our aim was to investigate the possible association of skin-tropic HPyVs with folliculitis, particularly eosinophilic pustular folliculitis (EPF). Read More

View Article and Full-Text PDF

Eosinophilic Dermatoses: Recognition and Management.

Am J Clin Dermatol 2020 Aug;21(4):525-539

Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Eosinophilic dermatoses encompass a broad spectrum of diseases of different etiologies hallmarked by eosinophilic infiltration of the skin and/or mucous membranes, with or without associated blood eosinophilia. The wide range of dermatological manifestations of this spectrum, including nodules and plaques, pustules, blisters, ulcers, and urticarial lesions, is reflected in a non-univocal classification system. We identified six groups of eosinophilic dermatoses based on the predominant anatomic level of involvement: (1) epidermal; (2) of the dermal-epidermal junction; (3) dermal; (4) of the hypodermis and muscle fascia; (5) of the pilosebaceous unit; and (6) vascular/perivascular. Read More

View Article and Full-Text PDF

Eosinophilic folliculitis of the scalp associated with PD-1/PDL1 inhibitors.

J Cosmet Dermatol 2020 Dec 12;19(12):3367-3370. Epub 2020 Apr 12.

Department of Ematology, Oncology and Dermatology, "Sapienza" University of Rome, Rome, Italy.

Background: Immune checkpoint inhibitors are monoclonal antibodies which target immune "checkpoints" enhancing T cell-mediated cytotoxic and antitumor responses. Together to the amazing results, these drugs are associated with some peculiar adverse events called immune-related adverse events. Alopecia is one of these. Read More

View Article and Full-Text PDF
December 2020